Investors interested in Technology Services stocks are likely familiar with Acuity (AYI) and Nomura Research Institute (NRILY) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores hi ...

Core Viewpoint - Investors in the Medical - Instruments sector should consider SONOVA HOLDING (SONVY) and Idexx Laboratories (IDXX) for potential value opportunities [1] Group 1: Zacks Rank and Earnings Outlook - SONOVA HOLDING has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Idexx Laboratories has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank system favors stocks with positive revisions to earnings estimates, suggesting that SONVY has an improving earnings outlook [3] Group 2: Valuation Metrics - SONVY has a forward P/E ratio of 20.72, significantly lower than IDXX's forward P/E of 43.44, indicating that SONVY may be undervalued [5] - The PEG ratio for SONVY is 3.14, while IDXX has a PEG ratio of 3.84, suggesting that SONVY offers better value when considering expected earnings growth [5] - SONVY's P/B ratio is 4.94 compared to IDXX's P/B of 31.37, further indicating that SONVY is more favorably valued [6] - Based on these valuation metrics, SONVY holds a Value grade of B, while IDXX has a Value grade of D, reinforcing SONVY as the superior value option [6]

Core Viewpoint - The comparison between Ambev (ABEV) and Brown-Forman B (BF.B) indicates that ABEV presents a better value opportunity for investors at this time due to its stronger earnings outlook and favorable valuation metrics [1][7]. Valuation Metrics - ABEV has a forward P/E ratio of 16.65, while BF.B has a forward P/E of 17.47, suggesting ABEV is more attractively priced [5]. - The PEG ratio for ABEV is 2.27, compared to BF.B's PEG ratio of 7.80, indicating ABEV's earnings growth is more reasonably priced [5]. - ABEV's P/B ratio stands at 3.05, while BF.B has a P/B of 3.35, further supporting ABEV's valuation advantage [6]. Analyst Outlook - ABEV currently holds a Zacks Rank of 2 (Buy), reflecting a more favorable earnings estimate revision trend compared to BF.B, which has a Zacks Rank of 3 (Hold) [3]. - The solid earnings outlook for ABEV positions it as the superior value option in the beverage-alcohol sector [7]. Value Grades - ABEV has been assigned a Value grade of B, while BF.B has a Value grade of D, highlighting ABEV's stronger valuation profile [6].

Core Viewpoint - The comparison between Merit Medical (MMSI) and Straumann Holding AG (SAUHY) indicates that MMSI is currently viewed as the better option for investors seeking undervalued stocks due to its stronger earnings estimate revisions and favorable valuation metrics [1][3]. Group 1: Zacks Rank and Earnings Estimates - MMSI has a Zacks Rank of 2 (Buy), while SAUHY has a Zacks Rank of 3 (Hold), suggesting that MMSI's earnings estimate revision activity is more favorable [3]. - The Zacks Rank system emphasizes stocks with strong earnings estimate revision trends, which is a positive indicator for MMSI [2]. Group 2: Valuation Metrics - MMSI has a forward P/E ratio of 20.07, compared to SAUHY's forward P/E of 28.57, indicating that MMSI may be undervalued relative to SAUHY [5]. - The PEG ratio for MMSI is 1.95, while SAUHY's PEG ratio is 2.78, further supporting the notion that MMSI offers better value based on expected EPS growth [5]. - MMSI's P/B ratio stands at 3.15, significantly lower than SAUHY's P/B of 8.14, reinforcing the argument for MMSI being the more attractive investment option [6]. Group 3: Value Grades - Based on various valuation metrics, MMSI holds a Value grade of B, while SAUHY has a Value grade of C, indicating that MMSI is perceived as a better value investment [6].

Core Viewpoint - Investors in the Diversified Operations sector should consider Sumitomo Corp. (SSUMY) and Honeywell International Inc. (HON) for potential value opportunities [1] Valuation Metrics - Sumitomo Corp. has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Honeywell has a Zacks Rank of 3 (Hold) [3] - SSUMY's forward P/E ratio is 12.69, significantly lower than HON's forward P/E of 22.67, suggesting SSUMY may be undervalued [5] - The PEG ratio for SSUMY is 1.47, compared to HON's PEG ratio of 3.46, indicating SSUMY's earnings growth is more favorably priced [5] - SSUMY has a P/B ratio of 1.36, while HON's P/B ratio is 9.68, further supporting SSUMY's valuation as more attractive [6] - These metrics contribute to SSUMY's Value grade of A and HON's Value grade of D, highlighting SSUMY as the superior value option [6][7] Earnings Outlook - SSUMY is experiencing an improving earnings outlook, which enhances its attractiveness in the current market [7]

Core Viewpoint - Investors are evaluating Becton Dickinson (BDX) and Straumann Holding AG (SAUHY) to determine which stock offers better value for investment opportunities [1] Valuation Metrics - BDX has a forward P/E ratio of 13.70, while SAUHY has a forward P/E of 27.58, indicating BDX is more attractively priced [5] - BDX's PEG ratio is 2.25, compared to SAUHY's PEG ratio of 2.69, suggesting BDX has a better balance of price to expected earnings growth [5] - BDX has a P/B ratio of 2.3, while SAUHY's P/B ratio is significantly higher at 7.86, further indicating BDX's relative undervaluation [6] Analyst Outlook - BDX holds a Zacks Rank of 2 (Buy), reflecting stronger earnings estimate revisions and a more favorable analyst outlook compared to SAUHY, which has a Zacks Rank of 3 (Hold) [3][7] - Based on the combination of valuation metrics and analyst outlook, BDX is considered the superior option for value investors at this time [7]

Core Viewpoint - Investors are evaluating Oddity Tech (ODD) and BlackLine (BL) to determine which stock offers better value opportunities in the Internet - Software sector [1] Group 1: Zacks Rank and Earnings Estimates - Oddity Tech has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings outlook, while BlackLine has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank emphasizes companies with positive earnings estimate revisions, suggesting that ODD's earnings outlook is improving more significantly than BL's [3] Group 2: Value Metrics - ODD has a forward P/E ratio of 14.54, compared to BL's forward P/E of 24.52, indicating that ODD may be undervalued relative to BL [5] - The PEG ratio for ODD is 1.22, while BL's PEG ratio is significantly higher at 4.98, suggesting ODD has better growth potential relative to its price [5] - ODD's P/B ratio is 5.15, while BL's P/B ratio is 10.84, further indicating that ODD is more attractively valued [6] Group 3: Overall Value Grades - ODD has received a Value grade of B, while BL has a Value grade of D, reinforcing the view that ODD is the more favorable investment option for value investors [6]

Core Viewpoint - Investors are evaluating Akzo Nobel NV (AKZOY) and Air Liquide (AIQUY) to determine which stock is more attractive for value investing [1] Group 1: Zacks Rank and Earnings Outlook - Akzo Nobel NV has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Air Liquide has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank system focuses on companies with positive earnings estimate revisions, suggesting that AKZOY has an improving earnings outlook [3] Group 2: Valuation Metrics - AKZOY has a forward P/E ratio of 13.34, significantly lower than AIQUY's forward P/E of 23.81 [5] - The PEG ratio for AKZOY is 0.94, while AIQUY's PEG ratio is 2.45, indicating that AKZOY is expected to grow earnings at a more favorable rate relative to its price [5] - AKZOY's P/B ratio is 2.45 compared to AIQUY's P/B of 3.74, further supporting AKZOY's valuation advantage [6] Group 3: Value Grades - Based on the valuation metrics, AKZOY has earned a Value grade of A, while AIQUY has a Value grade of C, highlighting AKZOY's superior value proposition [6] - Overall, AKZOY is considered the better value option due to its solid earnings outlook and favorable valuation figures [7]

Core Viewpoint - Investors are evaluating eToro Group Ltd. (ETOR) and Aon (AON) to determine which stock presents a better value opportunity for investment [1] Valuation Metrics - eToro Group Ltd. has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Aon has a Zacks Rank of 3 (Hold) [3] - ETOR's forward P/E ratio is 13.67, significantly lower than AON's forward P/E of 21.07, suggesting ETOR may be undervalued [5] - The PEG ratio for ETOR is 1.94, compared to AON's PEG ratio of 2.04, indicating that ETOR has a more favorable growth outlook relative to its valuation [5] - ETOR's P/B ratio stands at 2.12, while AON's P/B ratio is much higher at 9.45, further supporting the notion that ETOR is a more attractive value option [6] - Based on these valuation metrics, ETOR has a Value grade of A, whereas AON has a Value grade of D, highlighting ETOR's superior valuation profile [6]

Core Viewpoint - Investors in the Financial - Miscellaneous Services sector should consider Futu Holdings Limited Sponsored ADR (FUTU) and Brookfield Asset Management (BAM) as potential value opportunities [1] Group 1: Company Comparison - Futu Holdings Limited has a Zacks Rank of 2 (Buy), while Brookfield Asset Management has a Zacks Rank of 3 (Hold) [3] - FUTU has shown a stronger improvement in its earnings outlook compared to BAM [3] Group 2: Valuation Metrics - FUTU has a forward P/E ratio of 16.99, significantly lower than BAM's forward P/E of 33.50 [5] - The PEG ratio for FUTU is 0.53, indicating better value relative to its expected earnings growth, while BAM's PEG ratio is 2.18 [5] - FUTU's P/B ratio is 4.76, compared to BAM's P/B of 9.56, suggesting that FUTU is more undervalued based on market value versus book value [6] - Based on these valuation metrics, FUTU holds a Value grade of B, while BAM has a Value grade of D, indicating that FUTU is the superior value option [6]